Navigation Links
Lack of Brain Protein May Explain 'Rain Man' Abilities
Date:2/12/2008

Autistic savants learn some tasks better, but forget faster, study suggests

TUESDAY, Feb. 12 (HealthDay News) -- The lack of a particular brain protein may explain the phenomenon of "Rain Man" -- autistic savants who learn some tasks better but also forget faster, say researchers at Massachusetts Institute of Technology.

Mice genetically engineered to lack a key protein used for building synapses -- the junctions through which brain cells communicate -- actually learned a spatial memory task faster and better than normal mice, according to findings in the Feb. 13 issue of the Journal of Neuroscience. But when tested weeks later, the altered mice couldn't remember what they had learned as well as normal mice, and they had trouble remembering contexts that should have provoked fear.

"These opposite effects on different types of learning are reminiscent of the mixed features of autistic patients, who may be disabled in some cognitive areas but show enhanced abilities in others," study co-author Albert Y. Hung, a staff neurologist at Massachusetts General Hospital, said in a prepared statement. "The superior learning ability of these mutant mice in a specific realm is reminiscent of human autistic savants."

The absence of this important synaptic scaffold protein, called Shank1, may "trap" the mice's synapses into a state in which the synapses are ready to respond to input but not maintain it in long-term memory, he said.

In humans, mutations in the closely related protein Shank3 have been linked to the autism spectrum of disorders (ASD) characterized by impaired social interaction, absent or delayed language development and repetitive behaviors. Occasionally, an autistic person has an outstanding skill, such as an incredible rote memory or musical ability. Such individuals, like the character Dustin Hoffman played in the film "Rain Man," may be referred to as autistic savants.

More information

The National Dissemination Center for Children with Disabilities has more about autism.



-- Kevin McKeever



SOURCE: Massachusetts Institute of Technology, news release, Feb. 12, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Draining away brains toxic protein to stop Alzheimers
2. Vision restoration therapy shown to improve brain activity in brain injured patients
3. Clinical depression linked to abnormal emotional brain circuits
4. Brain imaging reveals breakdown of normal emotional processing
5. Brain cells work differently than previously thought
6. Vaccine Stops Alzheimers Brain Tangles
7. Research may unlock mystery of autisms origin in the brain
8. Scientists Spot Brains Free Will Center
9. Free will takes flight: how our brains respond to an approaching menace
10. Alcoholics With Cirrhosis Have More Brain Damage
11. Brain Lesions Predict MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lack of Brain Protein May Explain 'Rain Man' Abilities
(Date:3/23/2017)... ... March 23, 2017 , ... The ... from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart ... granted to organizations that have excellent programs for the delivery and improvement of ...
(Date:3/23/2017)... ... March 23, 2017 , ... March 23, 2017 - ... to easily reprint customer invoices, bills, statements and other correspondence when they have ... needed to retrieve and print the documents and batch them for efficient handling. ...
(Date:3/23/2017)... OR (PRWEB) , ... March 23, 2017 , ... Sharon ... Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on her program ... she also used the occasion to remind listeners of an important distinction. World Water ...
(Date:3/23/2017)... ... March 23, 2017 , ... Corra Group is ... competitive pricing. Verisys through its FACIS and other services maintains the ... actions. , “We are delighted to be able to offer these various products ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 ... will the new EU MDR language change the way manufacturers approach CERs? ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  Cornerstone Pharmaceuticals, Inc., a ... milestone today.  Following successful End-of-Phase I (EOP1) ... and Drug Administration (FDA), the Company has ... path forward to conduct pivotal trials of ... acute myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... March 23, 2017 Piramal ... Limited, anuncia el nombramiento de Stuart E. ... plataforma de servicios integrados completa para su base ... cargo clave en el crecimiento y ejecución de ... responsable de impulsar todas las actividades de desarrollo ...
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
Breaking Medicine Technology: